ZLAB
Zai Lab Ltd

1,229
Mkt Cap
$2.1B
Volume
728,393.00
52W High
$44.34
52W Low
$15.96
PE Ratio
-9.63
ZLAB Fundamentals
Price
$20.03
Prev Close
$18.77
Open
$19.74
50D MA
$18.14
Beta
1.17
Avg. Volume
798,805.25
EPS (Annual)
-$2.60
P/B
2.73
Rev/Employee
$213,583.80
$1,865.25
Loading...
Loading...
News
all
press releases
Zai Lab (NASDAQ:ZLAB) Shares Gap Up - Here's Why
Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next...
MarketBeat·1d ago
News Placeholder
More News
News Placeholder
JPMorgan Chase & Co. Has Lowered Expectations for Zai Lab (NASDAQ:ZLAB) Stock Price
JPMorgan Chase & Co. dropped their price objective on shares of Zai Lab from $46.00 to $39.00 and set an "overweight" rating on the stock in a research note on Thursday...
MarketBeat·9d ago
News Placeholder
$207B Market Shift: The Race for Fast Track Approval in Oncology
$207B Market Shift: The Race for Fast Track Approval in Oncology $207B Market Shift: The Race for Fast Track Approval in Oncology PR Newswire VANCOUVER, BC, Feb. 5, 2026 Issued on behalf of...
PR Newswire·9d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Sets New 12-Month Low - Here's Why
Zai Lab (NASDAQ:ZLAB) Hits New 1-Year Low - Time to Sell...
MarketBeat·15d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Stock Rating Upgraded by Jefferies Financial Group
Jefferies Financial Group raised shares of Zai Lab to a "strong-buy" rating in a report on Monday...
MarketBeat·25d ago
News Placeholder
Short Interest in Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Drops By 19.8%
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) was the target of a significant decline in short interest in December. As of December 31st, there was short interest totaling 4,248,996...
MarketBeat·27d ago
News Placeholder
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB) Receives Average Recommendation of "Moderate Buy" from Brokerages
Zai Lab Limited Unsponsored ADR (NASDAQ:ZLAB - Get Free Report) has earned a consensus recommendation of "Moderate Buy" from the nine research firms that are covering the company, MarketBeat reports...
MarketBeat·29d ago
News Placeholder
Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next?
Zai Lab (NASDAQ:ZLAB) Shares Gap Up - What's Next...
MarketBeat·1mo ago
News Placeholder
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today provided an update on the Companys 2026 strategic priorities and clinical development progress. These updates will be discussed as part of the...
Business Wire·1mo ago
News Placeholder
Zai Lab Announces National Medical Products Administration (NMPA) Approval of AUGTYRO (repotrectinib) for Patients with NTRK-Positive Solid Tumors
Zai Lab Limited (NASDAQ: ZLAB; HKEX: 9688) today announced that Chinas National Medical Products Administration (NMPA) has approved the supplemental New Drug Application (sNDA) for AUGTYRO...
Business Wire·1mo ago
<
1
2
...
>

Latest ZLAB News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.